| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Common Stock | Options Exercise | $108,773 | +25,179 | +181% | $4.32* | 39,115 | 25 Apr 2023 | Direct | F1 |
| transaction | MORF | Common Stock | Sale | $1,344,667 | -25,179 | -64% | $53.40 | 13,936 | 25 Apr 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Stock Option (right to buy Common Stock) | Options Exercise | $0 | -25,179 | -6.3% | $0.000000 | 376,371 | 25 Apr 2023 | Common Stock | 25,179 | $4.32 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes 395 shares of Common Stock acquired on February 28, 2022, and 862 shares of Common Stock acquired on February 28, 2023 under the Issuer's employee stock purchase plan. |
| F2 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022. |
| F3 | This option is fully vested. |